sr 48692 has been researched along with agar in 1 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (agar) | Trials (agar) | Recent Studies (post-2010) (agar) |
---|---|---|---|---|---|
203 | 3 | 36 | 10,357 | 38 | 1,953 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anini, Y; Gully, D; Laburthe, M; Maoret, JJ; Rouyer-Fessard, C | 1 |
1 other study(ies) available for sr 48692 and agar
Article | Year |
---|---|
Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice.
Topics: Agar; Animals; Cell Division; Colonic Neoplasms; Culture Media; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neurotensin; Polymerase Chain Reaction; Pyrazoles; Quinolines; Receptors, Neurotensin; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |